TGA Approval

CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial (356861)

ARTG ID

356861

ARTG Name

CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial

Sponsor

CSL Behring (Australia) Pty Ltd

ARTG Date

March 16, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Listed - Exempt

Sponsor Information

Sponsor Name

Sponsor Item Name

CSL BEHRING (AUSTRALIA) PTY LTD

Ingredient Name

Alpha-1-proteinase inhibitor

Empowering clinical research with data-driven insights and AI-powered tools.